Want to see NUS full AI Analyst Report?
NUS Stock Chart & Stats
$5.08
$0.06(1.18%)
At close: 4:00 PM EDT
$5.08
$0.06(1.18%)
Day’s Range― - ―
52-Week Range$4.49 - $14.62
Previous Close$5.17
Volume452.56K
Average Volume (3M)745.00K
Market Cap
$228.78M
Enterprise Value$328.94
Total Cash (Recent Filing)$189.64M
Total Debt (Recent Filing)$263.74M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Nov 04, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend Yield5.01%
Share Statistics
EPS (TTM)-4.45
Shares Outstanding48,676,636
10 Day Avg. Volume574,295
30 Day Avg. Volume744,997
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.32
P/FCF Ratio10.31
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1
Revenue Forecast (FY)$1.43B
Bulls Say, Bears Say
Bulls Say
Cost ManagementCost savings initiatives, accelerated SKU rationalization plan, and promo/discount management are viewed positively.
InnovationNUS is working to stimulate its core business with innovation and refreshed business models in select markets.
Bears Say
Guidance And PerformanceThe company lowered 2024 net sales and EPS guidance citing pressure across the P&L from tough macros, greater FX headwinds, negative mix on GM, increased selling expense, and higher taxes.
Market ConditionsThe stock is down about 40% since reporting 2Q’24 results, reflecting weaker macroeconomic conditions and removal from the S&P 600 index.
Sales OutlookThe 3Q’24/2024 CC sales outlook has worsened as macros and beauty category trends have softened.
Nu Skin News
NUS FAQ
What was Nu Skin Enterprises’s price range in the past 12 months?
Nu Skin Enterprises lowest stock price was $4.49 and its highest was $14.62 in the past 12 months.
What is Nu Skin Enterprises’s market cap?
Nu Skin Enterprises’s market cap is $228.78M.
When is Nu Skin Enterprises’s upcoming earnings report date?
Nu Skin Enterprises’s upcoming earnings report date is Nov 04, 2026 which is in 76 days.
How were Nu Skin Enterprises’s earnings last quarter?
Nu Skin Enterprises released its earnings results on Aug 10, 2026. The company reported $0.2 earnings per share for the quarter, the consensus estimate of $0.2 by $0.
Is Nu Skin Enterprises overvalued?
According to Wall Street analysts Nu Skin Enterprises’s price is currently Overvalued.
Does Nu Skin Enterprises pay dividends?
Nu Skin Enterprises pays a Quarterly dividend of $0.06 which represents an annual dividend yield of 5.01%. See more information on Nu Skin Enterprises dividends here
What is Nu Skin Enterprises’s EPS estimate?
Nu Skin Enterprises’s EPS estimate is 0.21.
How many shares outstanding does Nu Skin Enterprises have?
Nu Skin Enterprises has 48,676,636 shares outstanding.
What happened to Nu Skin Enterprises’s price movement after its last earnings report?
Nu Skin Enterprises reported an EPS of $0.2 in its last earnings report, expectations of $0.2. Following the earnings report the stock price went down -5.437%.
Which hedge fund is a major shareholder of Nu Skin Enterprises?
Currently, no hedge funds are holding shares in NUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nu Skin Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NUS Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.59%
12-Months-Change
Fundamentals
Return on Equity
5.01%
Trailing 12-Months
Asset Growth
-22.32%
Trailing 12-Months
Company Description
Nu Skin Enterprises
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
NUS Company Deck
NUS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: strong product momentum and engagement around Prysm iO, improved core gross margin, cost reductions in G&A, and disciplined liquidity position are notable positives. However, sizable non-cash goodwill and deferred tax charges materially impacted reported earnings, adjusted operating margins declined, recruiting and leadership development remain weak, and the India launch was delayed. Near-term FX headwinds and modest operating cash flow further temper the outlook. On balance, the company shows encouraging strategic traction and product adoption but faces meaningful near-term financial and operational headwinds.View all NUS earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
The Estée Lauder Companies
―
Coty
―
Edgewell Personal Care
―
e.l.f. Beauty
―
Beauty Health
―
Ownership Overview
5.35% Insiders
15.47% Mutual Funds
9.61% Other Institutional Investors
46.87% Public Companies and
Individual Investors







